At Innoforce, we developed both enzymatic capping and co-capping process to flexibly meet clients’ requirements. For both capping approaches, the capping efficiency reached over 98% applying platform process.

Thanks to the unique plasmid manufacturing process and In Vitro Transcription (IVT) process, the existing of impurities such as dsRNA was well controlled, and it largely released the pressure in downstream purification. The purity of mRNA was proved to be high in all three platforms, linear mRNA, circular RNA and self-amplifying RNA.